Financials
Financial year 2025
Revenue
€ 55.2 million
▲ 9% vs 2024
Profit
Caution€ -1.2 million
▼ 105% vs 2024
Debts
Low€ 31.2 million
▲ 7% vs 2024
KELA - Kempisch Laboratorium - Kela Laboratoria from Hoogstraten, company number BE0403835645, closed financial year 2025 with a result of € -1.2 million after tax. For that financial year KELA - Kempisch Laboratorium - Kela Laboratoria recorded revenue of € 55.2 million and equity of € 31.9 million. Compared with financial year 2024, the result moved from € 23.8 million to € -1.2 million. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 1, 2026.
What happened at KELA - Kempisch Laboratorium - Kela Laboratoria?
What happened at KELA - Kempisch Laboratorium - Kela Laboratoria in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 1.2 million (▼ 105% vs 2024). Source: NBB ↗
- Voxdale NV became a director. NBB
- Start of the company according to the CBE. KBO
- New establishment in Hoogstraten. KBO
In short
From € 1.2 million profit in 2021 to € 1.2 million loss in 2025.
Paid € 594,460 in corporate taxes since 2021.
Best year ever: 2024, with € 23.8 million profit.
Pays suppliers within 74 days on average.
A new publication or filing at KELA - Kempisch Laboratorium - Kela Laboratoria? We notify you, reason included.
Follow KELA - Kempisch Laboratorium - Kela LaboratoriaNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind KELA - Kempisch Laboratorium - Kela Laboratoria is Voxdale NV. It owns 200% of ANUPCO LTD, 199% of KELA DE LAS AMERICAS, 100% of KELA HONG KONG LTD, 98% of PHENIX PROPERTY, 49% of SARL GROUPE PHARMACEUTIQUE MADANI KELA G.P.M.K. and 49% of KELA THAILAND LTD itself.
Directors
According to the 2025 annual accounts
Director · represented by Pascal BEYENS
Also active at: KELA VETERINARIA, PHENIX PROPERTY, Medicem
since 2023
Establishments
Establishment units
Physical locations of this company
Sint Lenaartseweg 48
2320 Hoogstraten
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
Details
- Company number
- 0403.835.645
- VAT number
- BE 0403.835.645
- Registered office
- Sint Lenaartseweg 48, 2320 Hoogstraten
- Names & denominations
- KELA - Kempisch Laboratorium - Kela Laboratoria · Kela
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 15 July 1941
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Vervaardiging van geneesmiddelen